Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Continues Busy Year With Perrigo Offer

This article was originally published in The Pink Sheet Daily

Executive Summary

Still integrating businesses gained from Abbott and Famy Care, Mylan proposes a $205-per-share bid for Perrigo, which itself just closed a $4.5 billion takeout of Omega Pharma.

You may also be interested in...



Perrigo’s Irish Move Sets Stage For International Boost, Net Revenue Gain

OTC private label leader Perrigo acquires Irish firm Elan for $8.6 billion in a deal that will bring tax savings from being incorporated in Ireland, provide a stage for European expansion and tap into Elan’s royalty rights. “Simply stated, we're going to be able to further our international platform,” CEO Joseph Papa says.

Colgate Says Hello To Subscription-Delivery Wtih Oral Care Line Acquisition

Colgate agrees to purchase Hello Products direct-to-consumer oral care brand, complementing  its Colgate brand and its Tom’s of Maine natural-positioned line. The firm will pay with a combination of cash and debt in the deal expected to close no later than the end of February.

Grooming Investments Pay Off, Merck OTCs Count Organically In P&G's Latest Quarter

P&G’s grooming segment grew 4% in its latest quarter, the third consecutive of organic growth as the Gillette brand wins 18m customers in 12 months. The results suggest investments the company made to ward off subscription-based competitors are starting to pay off.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

PS078452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel